Mice Model Market to Reach $2.74 Billion by 2030
The global Mice Model Market is projected to grow from USD 1.70 billion in 2025 to USD 2.74 billion by 2030, registering a CAGR of 10.0% during the forecast period. Growth is being fueled by increasing reliance on mice models in preclinical research, rising adoption of mouse clinical trials (MCTs), and expanding applications in personalized medicine—particularly in oncology.
Download...
Human Organoids Market to Reach $2.33 Billion by 2029
The global Human Organoids Market is gaining significant strategic traction as life sciences organizations accelerate the shift toward more predictive, ethical, and cost-efficient research models. Valued at USD 1.19 billion in 2024, the market is projected to reach USD 2.33 billion by 2029, growing at a CAGR of 14.4% during the forecast period. This growth underscores a critical transformation...
Humanized Mouse and Rat Model Market: Accelerating Drug Discovery and Precision Medicine Growth
The global humanized mouse and rat model market is witnessing strong momentum, driven by the increasing complexity of drug discovery and the rising demand for personalized medicine. Valued at approximately USD 255.8 million in 2024, the market is projected to reach USD 409.8 million by 2030, expanding at a CAGR of 8.2%. This growth reflects the expanding role of advanced preclinical models in improving...
Why the US Infection Control Market Is Becoming a Critical Pillar of Modern Healthcare
The US healthcare system is undergoing a major transformation, and one area gaining unprecedented attention is infection control. From hospitals and ambulatory surgical centers to laboratories and long-term care facilities, healthcare providers are investing heavily in advanced infection prevention technologies to reduce healthcare-associated infections (HAIs), improve patient safety, and comply with...
Biobanking Market to Reach $11.82 Billion by 2030
The global Biobanking Market is projected to grow from USD 7.65 billion in 2025 to USD 11.82 billion by 2030, registering a CAGR of 9.1% during the forecast period. Market expansion is being driven by the increasing focus on precision medicine, a rapidly growing cell and gene therapy pipeline, and advancements in automated sample handling and storage technologies.
Download...
HLA Typing for Transplant Market to Reach $1.4 Billion by 2030
The global HLA Typing for Transplant Market is projected to grow from USD 1.1 billion in 2025 to USD 1.4 billion by 2030, at a CAGR of 6.0% during the forecast period. Market expansion is being driven by the rising volume of organ transplantation procedures, advancements in molecular diagnostic technologies, and increasing investments in transplant research and infrastructure.
Download...
Molecular Diagnostics Market to Reach $30.74 Billion by 2030
According to MarketsandMarkets™, The report “Molecular Diagnostics Market by Product & Service (Kits, Instruments, Software), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH), and Application (Infectious (Hepatitis, HIV, HAI, Flu), Cancer (Breast, Lung)) – Global Forecast to 2030″, is valued at an estimated USD 19.48 billion in 2025 and is projected...
Medical Radiation Detection Market: Advancing Safety, Precision, and Operational Excellence in Healthcare
The global healthcare industry is entering a phase where precision diagnostics and patient safety must evolve together. As imaging volumes continue to rise across hospitals, diagnostic centers, and specialty care facilities, the importance of advanced radiation detection technologies has become increasingly strategic. The growing adoption of diagnostic imaging, radiation therapy, and nuclear medicine...
Neurological Biomarkers Market to Reach $9.91 Billion by 2030
The global Neurological biomarkers market is projected to grow from USD 5.53 billion in 2025 to USD 9.91 billion by 2030, at a CAGR of 10.7%. This growth reflects the accelerating shift toward precision neurology and data-driven clinical decision-making. Amid the growing global burden of neurological disorders, the role of biomarkers in transforming diagnosis and therapeutic development...